Clorox is trading at $101.05 (+4.9%) in pre-market, staging a recovery after a period of weak sentiment tied to a reduced fiscal 2026 outlook and mixed financial results.
- The company's recent Q2 FY2026 report showed an EPS miss but a modest revenue beat, with organic sales impacted by an ongoing ERP transition.
- Traders appear to be repositioning ahead of the next earnings call on August 3, 2026, supported by a broader lift in equity futures.
- The rebound follows a significant reset in expectations after the company previously lowered its long-term guidance.